Versor Investments LP Eli Lilly & CO Transaction History

Versor Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $807,237 - $1.11 Million	1,857 New	1,857 $997,000
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $752,448 - $870,342	-5,146 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $702,017 - $844,870	5,146 New	5,146 $845,000
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $1.15 Million - $1.43 Million	-10,800 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $2.09 Million - $2.28 Million	-19,600 Reduced 64.47%	10,800 $1.21 Million
Q2 2019 Jul 29, 2019	BUY	$110.79 - $129.32 $3.37 Million - $3.93 Million	30,400 New	30,400 $3.37 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.